These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12786673)

  • 1. Management of hyperglycaemia in the patient with acute myocardial infarction.
    Nattrass M
    Diabet Med; 2003 Jun; 20 Suppl 3():11-3. PubMed ID: 12786673
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose-tolerance testing in acute myocardial infarction.
    Haffner SM
    Lancet; 2002 Jun; 359(9324):2127-8. PubMed ID: 12090974
    [No Abstract]   [Full Text] [Related]  

  • 3. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
    Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2015 updated position statement of the management of hyperglycaemia in type 2 diabetes].
    Scheen AJ; Paquot N
    Rev Med Suisse; 2015 Aug; 11(483):1518, 1520-5. PubMed ID: 26502577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of diabetes and hyperglycaemia during myocardial infarction: review of the literature.
    Walker EF
    Intensive Crit Care Nurs; 1999 Oct; 15(5):259-65. PubMed ID: 10808822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.
    Ariturk Z; Islamoglu Y; Gündüz E; Yavuz C; Cil H; Tekbas E; Soydinc S; Kaya H; Elbey MA
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):617-21. PubMed ID: 22774402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myocardial infarction.
    Moher M
    Br J Gen Pract; 1995 Aug; 45(397):444-5. PubMed ID: 7576862
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus.
    Galligan A; Greenaway TM
    Intern Med J; 2016 May; 46(5):540-9. PubMed ID: 27170238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 11. Do comorbidities influence the treatment of myocardial infarction?
    Passman R; Kimmel S
    J Gen Intern Med; 1997 Jan; 12(1):73-4. PubMed ID: 9034950
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia.
    Dandona P; Aljada A; Bandyopadhyay A
    Diabetes Care; 2003 Feb; 26(2):516-9. PubMed ID: 12547892
    [No Abstract]   [Full Text] [Related]  

  • 13. Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke.
    Floyd JS; Wiggins KL; Sitlani CM; Flory JH; Dublin S; Smith NL; Heckbert SR; Psaty BM
    Diabetes Obes Metab; 2015 Dec; 17(12):1194-7. PubMed ID: 26179389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycaemia in inpatients with type 2 diabetes mellitus.
    Mohan S; Fenton DR; Solomon A; de Wolff JF
    Br J Hosp Med (Lond); 2012 Aug; 73(8):C124-8. PubMed ID: 22875479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Ann Med; 2014 Aug; 46(5):335-40. PubMed ID: 24785356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancing reperfusion therapy for myocardial infarction with dual antiplatelet therapy: Breaking the glass ceiling.
    Fathi RB; Bhatt DL
    Am Heart J; 2005 Jun; 149(6):947-9. PubMed ID: 15976770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
    Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
    Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.